BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2671280)

  • 1. Doctor-patient communication about breast cancer adjuvant therapy.
    Siminoff LA; Fetting JH; Abeloff MD
    J Clin Oncol; 1989 Sep; 7(9):1192-200. PubMed ID: 2671280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discussing adjuvant cancer therapy.
    Leighl N; Gattellari M; Butow P; Brown R; Tattersall MH
    J Clin Oncol; 2001 Mar; 19(6):1768-78. PubMed ID: 11251008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The choice is yours? How women with ovarian cancer make sense of treatment choices.
    Ziebland S; Evans J; McPherson A
    Patient Educ Couns; 2006 Sep; 62(3):361-7. PubMed ID: 16876377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [General evaluation of adjuvant chemotherapy trials in breast cancer (excluding the Milan trial)].
    Gest J
    Bull Cancer; 1984; 71(4):336-44. PubMed ID: 6388672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.
    Melisko ME; Hassin F; Metzroth L; Moore DH; Brown B; Patel K; Rugo HS; Tripathy D
    Clin Breast Cancer; 2005 Apr; 6(1):45-54. PubMed ID: 15899072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors.
    Siminoff LA; Graham GC; Gordon NH
    Patient Educ Couns; 2006 Sep; 62(3):355-60. PubMed ID: 16860520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information and communication in the context of a clinical trial.
    Hietanen P; Aro AR; Holli K; Absetz P
    Eur J Cancer; 2000 Oct; 36(16):2096-104. PubMed ID: 11044647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials.
    Rajagopal S; Goodman PJ; Tannock IF
    J Clin Oncol; 1994 Jun; 12(6):1296-304. PubMed ID: 8201392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results].
    Kahlert S; von Koch F; Ditsch N; Untch M
    Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):102-12. PubMed ID: 15073439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy for early stage breast cancer.
    Sledge GW
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):51-4. PubMed ID: 8614845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 Sep; 352(9132):930-42. PubMed ID: 9752815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study of factors affecting chemotherapy use in older women with breast cancer: barriers, promoters, and implications for intervention.
    Kreling B; Figueiredo MI; Sheppard VL; Mandelblatt JS
    Psychooncology; 2006 Dec; 15(12):1065-76. PubMed ID: 16598833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-physician communication concerning participation in cancer chemotherapy trials.
    Sørensen JB; Rossel P; Holm S
    Br J Cancer; 2004 Jan; 90(2):328-32. PubMed ID: 14735172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision-making from multidisciplinary team meetings to the bedside: factors influencing the recruitment of breast cancer patients into clinical trials.
    Mazouni C; Deneuve J; Arnedos M; Prenois F; Saghatchian M; André F; Bourgier C; Delaloge S
    Breast; 2014 Apr; 23(2):170-4. PubMed ID: 24411195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials referral resource. Adjuvant therapy of breast cancer.
    Cheson BD
    Oncology (Williston Park); 1989 Jun; 3(6):70-1, 74-5, 78. PubMed ID: 2534915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.